LIVN LivaNova PLC
$78.18▲ +0.00%
Healthcare
Other
After hours
$78.18▲ +0.00%
Sep 11, 7:30 PM ET
Volume 552.4K
Avg Volume (10D) 562.7K
Key Metrics & Fundamentals
Market Cap
$4.29B
P/E Ratio
23.1
Div Yield
–%
52W Range
48.82 - 85.76
% vs 50 MA
-2.74%
% vs 200 MA
11.23%
RSI-14
43.7
MACD Histogram
-0.2300
Beta (1Y vs SPY)
1.03
Free Cash Flow
$35.04M
Gross Rev
$390.59M
Gross Profit
$273.67M
EBITDA
$71.62M
COGS
$116.92M
Operating Exp
$224.19M
Operating Income
$49.48M
EBIT
$49.48M
Pretax Income
$18.48M
Net Income
$108.57M
EPS (Diluted)
1.93
Price & Volume History
Loading chart…
Recent News

LivaNova Director Sells 1,650 Shares for $131,500
Motley Fool · Sep 11, 2026 1:15 AM
GHO Capital appoints Vivid Sehgal as Operating Partner
GlobeNewswire · Sep 8, 2026 8:00 AM

LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
Business Wire · Sep 3, 2026 1:00 PM

Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)
Simply Wall St. · Aug 12, 2026 11:16 PM

LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance
Simply Wall St. · Aug 12, 2026 10:09 PM

LivaNova (LIVN) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 3:34 PM
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
Zacks · Aug 6, 2026 4:31 PM
LivaNova PLC Q2 2026 Earnings Call Summary
Moby · Aug 5, 2026 10:03 PM
LivaNova PLC (LIVN) (Q2 2026) Earnings Call Highlights: Record Revenue and EPS, Raised Guidance ...
GuruFocus.com · Aug 5, 2026 7:02 PM
LivaNova Q2 Earnings Call Highlights
MarketBeat · Aug 5, 2026 5:04 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LIVN's money flow as a full page
Social Sentiment
Avg +0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.